Luigi Piero Stasi

Title: Luigi Piero Stasi: Innovator in Pharmaceutical Chemistry

Introduction

Luigi Piero Stasi is a notable inventor based in Monza, Italy, recognized for his contributions to pharmaceutical chemistry. With a total of 8 patents to his name, he has made significant advancements in the field, particularly in the development of compounds with therapeutic applications.

Latest Patents

Among his latest patents, Stasi has developed spiro aminic compounds with NK1 antagonist activity. This invention concerns a spiro-amino compound of Formula (I), wherein A is selected from a 5- or 6-membered aromatic ring and a 5- or 6-membered heteroaromatic ring containing 1 to 3 nitrogen atoms. The substituents X and Y are selected from various groups, including (C-C)alkyl, halogen, and trifluoromethyl, or a pharmaceutically acceptable salt thereof, aimed at treating pathologies requiring an antagonist of the NK1 receptor. Another significant patent involves 4,4-difluoro-piperidine compounds, which relates to compounds of formula (I) or a pharmaceutically acceptable salt thereof.

Career Highlights

Stasi has worked with prominent companies in the pharmaceutical industry, including Rottapharm Biotech S.r.l. and Rottapharm S.r.l. His work in these organizations has contributed to the development of innovative therapeutic solutions.

Collaborations

Throughout his career, Stasi has collaborated with esteemed colleagues such as Lucio C Rovati and Manuela Borriello. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Luigi Piero Stasi is a distinguished inventor whose work in pharmaceutical chemistry has led to the development of important therapeutic compounds. His contributions continue to impact the field positively.